Phase II chronic study on the ARSACS mouse not to be pursued

In Research in 2015 by ARSACS

The phase II chronic study on the ARSACS mouse with respect to a compound is now at a wrap up stage. The conclusions of the study can be summarized by a problematic delivery of the compound. Therefore, the study will not be pursued further.